Pharma Mar, S.A. (LON:0RC6)
London · Delayed Price · Currency is GBP · Price in EUR 76.25
-0.15 (-0.20%)
Feb 12, 2026, 4:07 PM GMT
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of 1.14 billion as of February 12, 2026. Its market cap has decreased by -14.13% in one year.
Market Cap
1.14B
Enterprise Value
1.05B
Revenue
156.48M
Ranking
n/a
PE Ratio
38.34
Stock Price
76.25
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.29B to 1.14B, a decrease of -11.48%. That is a compound annual growth rate of -1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.14B | 1.19% |
| Dec 31, 2025 | 1.12B | -2.10% |
| Dec 31, 2024 | 1.15B | 79.24% |
| Dec 29, 2023 | 640.85M | -37.61% |
| Dec 30, 2022 | 1.03B | 18.56% |
| Dec 30, 2021 | 866.42M | -26.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.09B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| PureTech Health | 312.74M |
| Avacta Group | 260.26M |
| Scancell Holdings | 128.68M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |